Filing Details
- Accession Number:
- 0001127602-24-027086
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-11-12 17:37:30
- Reporting Period:
- 2024-11-07
- Accepted Time:
- 2024-11-12 17:37:30
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 943819 | Resmed Inc | RMD | Surgical & Medical Instruments & Apparatus (3841) | 980152841 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1485164 | J. Michael Farrell | Resmed Inc. 9001 Spectrum Center Blvd San Diego CA 92123 | Chief Executive Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Resmed Common Stock | Acquisiton | 2024-11-07 | 14,683 | $84.98 | 478,937 | No | 4 | M | Direct | |
| Resmed Common Stock | Disposition | 2024-11-07 | 14,683 | $246.26 | 464,254 | No | 4 | S | Direct | |
| Resmed Common Stock | Disposition | 2024-11-11 | 3,101 | $252.38 | 461,152 | No | 4 | F | Direct | |
| Resmed Common Stock | Disposition | 2024-11-11 | 2,227 | $252.38 | 458,925 | No | 4 | F | Direct | |
| Resmed Common Stock | Disposition | 2024-11-11 | 3,453 | $252.38 | 455,472 | No | 4 | F | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | F | Direct | |
| No | 4 | F | Direct | |
| No | 4 | F | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Resmed Common Stock | ResMed Common Stock Options | Disposition | 2024-11-07 | 14,683 | $0.00 | 14,683 | $84.98 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2018-11-11 | 2024-11-16 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Resmed Common Stock | 4,090 | Indirect | Lisette and Michael Farrell Family Trust |
Footnotes
- The transaction was conducted under a Rule 10b5-1 plan adopted January 31, 2024.
- Includes 84.129 shares of ResMed stock purchased on October 31, 2024, through the ResMed Employee Stock Purchase Plan.
- The transaction was conducted under a Rule 10b5-1 plan adopted January 31, 2024.
- This transaction was executed in multiple trades at prices ranging from $244.74 - $248.38 The price reported above reflects the weighted average sale price.
- Disposition to issuer for tax withholding on vesting of Restricted Stock Units granted on 11/18/2021.
- Disposition to issuer for tax withholding on vesting of Restricted Stock Units granted on 11/16/2022.
- Disposition to issuer for tax withholding on vesting of Restricted Stock Units granted on 11/16/2023.
- The transaction was conducted under a Rule 10b5-1 plan adopted January 31, 2024.
- Represents date options first become exercisable. Options vest 1/3 per year.
Billionaire Hedge Funds
